CoChat

Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

Abstract

Background Cardiovascular diseases (CVD) represent a heavy economic burden on individuals, health services, and society. Low adherence to antihypertensive (AH) agents is acknowledged as a major contributor to the lack of blood pressure control, and may have a significant impact on clinical outcomes and healthcare costs. Objectives To evaluate the impact of low adherence to AH agents on cardiovascular outcomes and hospitalization costs. Methods A cohort of 59,647 patients with essential hypertension was reconstructed from the Régie de l'assurance maladie du Québec and Med-Echo databases. Subjects included were between 45 and 85 years of age, without any evidence for symptomatic CVD, newly treated with AH agents between 1999 and 2002 and followed-up for a 3-year period. Adherence to AH agents was categorized as >or=80% or Results Patients with low adherence were more likely to have coronary disease (OR, 1.07; 95% confidence interval [CI], 1.00-1.13), cerebrovascular disease (OR, 1.13; 95% CI, 1.03-1.25), and chronic heart failure (OR, 1.42; 95% CI, 1.27-1.58) within the 3-year follow-up period. Among hospitalized patients, low adherence to AH therapy was associated with increased costs by approximately $3574 (95% CI, $2897-$4249) per person within a 3-year period. Conclusions Low adherence to AH agents is correlated with a higher risk of vascular events, hospitalization, and greater healthcare costs. An increased level of adherence to AH agents should provide a better health st…

Overview

Integrity signals

Registry

Crossref · 10.1097/mlr.0b013e3181d567bd

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 221

Metadata

Authors
Dragomir, A., Côté, R., Roy, L., Blais, L., Lalonde, L., Bérard, A., & Perreault, S.
Affiliations
  • Université de Montréal (CA)
  • McGill University (CA)
Corresponding author
  • Dragomir, Alice
  • Blais, Lucie
  • Lalonde, Lyne
  • Bérard, Anick
  • Perreault, Sylvie
Venue
Medical Care
Published
2010-05
Volume
48
Issue
5
Pages
418-425
ISSN
0025-7079 (ISSN-L)
OpenAlex
W1966704625
Cited by
221
References
41
Citations by year
2026: 9 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 19 · 2021: 6 · 2020: 14 · 2019: 16 · 2018: 13 · 2017: 20 · 2016: 13 · 2015: 14 · 2014: 20 · 2013: 21 · 2012: 20
FWCI
16.24
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Keywords
antihypertensive drugs, medication adherence, essential hypertension, cardiovascular disease, hospital costs, coronary disease, cerebrovascular disease, chronic heart failure, health care costs, blood pressure control
MeSH terms
Assessment of Medication Adherence, Age Factors, Aged, Aged, 80 and over, Antihypertensive Agents, Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Artery Disease, Drug Therapy, Combination, Female, Heart Failure, Hospitalization, Humans, Hypertension, Insurance Claim Review, Male, Middle Aged, Sex Factors, Cohort Studies, Treatment Outcome, Drug Monitoring, Hospital Charges, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.